Submitted by Anonymous (not verified) on 4 October 2023 - 15:41
Human medicines European public assessment report (EPAR): Fosavance, alendronic acid,colecalciferol, Osteoporosis, Postmenopausal, Date of authorisation: 24/08/2005, Revision: 27, Status: Authorised
Source: